Mushroom’s natural compound cut off
Print Edition
Chinese researchers have isolated a natural compound from Ganoderma mushrooms, commonly used in traditional Chinese medicine, which suppresses tumor growth.
By altering lipid metabolism and triggering cell death, the natural compound of GL22 sharply inhibits the growth of the liver cancer cell both in living organisms as well as lab tests of just the cell.
Researchers with the Chinese Academy of Sciences demonstrated that GL22 treatment decreases the expression of fatty acid-binding proteins and causes the liver cancer cell to die.
FABPs act as intracellular fatty acid transporters. They coordinate lipid responses in cells and are strongly linked to metabolic pathways.
Cancer is characterized by uncontrolled, rapid tumor cell growth. This growth triggers an enormous surge in the production of building blocks, including nucleic acids, fatty acids and amino acids.
Reprogramming the lipid metabolic pathway is one of the most significant alterations in tumor cells.
The research results support targeting lipid metabolism via manipulated FABPs as a cancer treatment strategy, and promote the use of Ganoderma mushrooms in Chinese medicine as an important source of anti-cancer drugs.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
